Yes, multiplexing is instrumental in the drug development process. It allows researchers to simultaneously assess the effects of new drugs on multiple targets and pathways. This can help identify potential off-target effects and toxicities early in the development process, accelerating the discovery of effective and safe cancer therapies.
